Photo from wikipedia
Premature dual antiplatelet therapy interruption (DAPTi) is a challenging problem in patients with hematologic malignancies after percutaneous coronary intervention (PCI). The epidemiology and impact of DAPTi in these patients is… Click to show full abstract
Premature dual antiplatelet therapy interruption (DAPTi) is a challenging problem in patients with hematologic malignancies after percutaneous coronary intervention (PCI). The epidemiology and impact of DAPTi in these patients is not known. 64 patients with active hematologic malignancy at Memorial
Keywords:
patients active;
interruption;
dual antiplatelet;
antiplatelet therapy
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!